Enzymotec to Report Third Quarter 2016 Financial Results

MIGDAL HA'EMEQ, Israel, Nov. 02, 2016 -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that the Company will release financial results for the third quarter ended September 30, 2016 on Wednesday, November 16, 2016, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will host a conference call to review the financial results.
                                                                                                                                                                             
The conference call is scheduled to begin at 8:30 am ET on Wednesday, November 16, 2016. Participants should dial (877) 359-9508 (United States) or (224) 357-2393 (International) with confirmation code #12583905 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://edge.media-server.com/m/p/7bvtahd6, and will be archived online within one hour of its completion.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit http://www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035 / 7012
[email protected]
[email protected]